Dikmen, P. Y. Et Al. 2017. What happens when chronic migraine patients quit onabotulinumtoxina?. 18th International Headache Congress (IHC) of the International-Headache-Society , (Vancouver, Canada), 85-86.

Dikmen, P. Y., Kosak, S., Aydinlar, E., & Kocaman, A., (2017). What happens when chronic migraine patients quit onabotulinumtoxina? . 18th International Headache Congress (IHC) of the International-Headache-Society (pp.85-86). Vancouver, Canada

Dikmen, Pinar Et Al. "What happens when chronic migraine patients quit onabotulinumtoxina?," 18th International Headache Congress (IHC) of the International-Headache-Society, Vancouver, Canada, 2017

Dikmen, Pinar Y. Et Al. "What happens when chronic migraine patients quit onabotulinumtoxina?." 18th International Headache Congress (IHC) of the International-Headache-Society , Vancouver, Canada, pp.85-86, 2017

Dikmen, P. Y. Et Al. (2017) . "What happens when chronic migraine patients quit onabotulinumtoxina?." 18th International Headache Congress (IHC) of the International-Headache-Society , Vancouver, Canada, pp.85-86.

@conferencepaper{conferencepaper, author={Pinar Yalinay Dikmen Et Al. }, title={What happens when chronic migraine patients quit onabotulinumtoxina?}, congress name={18th International Headache Congress (IHC) of the International-Headache-Society}, city={Vancouver}, country={Canada}, year={2017}, pages={85-86} }